Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
暂无分享,去创建一个
Ornella Parolini | Mary Ellen Conley | Satoshi Tsukada | David J. Rawlings | T. Mohandas | J. Belmont | O. Witte | D. Rawlings | M. Cooper | M. Conley | O. Parolini | R. Sparkes | S. Quan | Douglas C. Saffran | R.Cutler Allen | Ivana Klisak | Robert S. Sparkes | Hiromi Kubagawa | Thuluvancheri Mohandas | Shirley Quan | John W. Belmont | Max D. Cooper | Owen N. Witte | D. Saffran | I. Klisak | H. Kubagawa | S. Tsukada | R. Allen
[1] R. Nussbaum,et al. Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. , 1989, Genomics.
[2] T. Hunter,et al. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.
[3] T. Roberts,et al. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src , 1987, Cell.
[4] Allan Bradley,et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.
[5] G. Mardon,et al. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant , 1988, Molecular and cellular biology.
[6] J. Hutchcroft,et al. Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor. , 1992, The Journal of biological chemistry.
[7] M. Conley. B cells in patients with X-linked agammaglobulinemia. , 1985, Journal of immunology.
[8] T. Yamamoto,et al. Association of B cell antigen receptor with protein tyrosine kinase Lyn. , 1991, Science.
[9] O. Witte,et al. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Belmont,et al. Linkage analysis and physical mapping near the gene for X-linked agammaglobulinemia at Xq22. , 1993, Genomics.
[11] P. Thompson,et al. Expression and interactions of the Src family of tyrosine protein kinases in T lymphocytes. , 1991, Advances in cancer research.
[12] R. Bronson,et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.
[13] J. Singer,et al. Expression of the gene defect in X-linked agammaglobulinemia. , 1986, The New England journal of medicine.
[14] H. Varmus,et al. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells , 1987, Molecular and cellular biology.
[15] I. Scher,et al. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. , 1982, Advances in immunology.
[16] S. Desiderio,et al. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] K. Kammermeyer,et al. Primary sequence and developmental expression of a novel Drosophila melanogaster src gene , 1987, Molecular and cellular biology.
[18] T. Yamamoto,et al. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. , 1991, The Journal of biological chemistry.
[19] H. Hirai,et al. Human ltk: gene structure and preferential expression in human leukemic cells. , 1990, Oncogene research.
[20] K. Tada,et al. Epstein‐Barr Virus‐induced Lymphoblastoid Cell Lines from Patients with Primary Immunodeficiency Diseases , 1980, Scandinavian journal of immunology.
[21] W. Northemann,et al. Production of recombinant rat interleukin-6 in Escherichia coli using a novel highly efficient expression vector pGEX-3T. , 1992, BioTechniques.
[22] J. Belmont,et al. Dinucleotide repeat polymorphism at the DXS178 locus. , 1992, Human Molecular Genetics.
[23] O. Witte,et al. Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells , 1993, The Journal of experimental medicine.
[24] B. Alter,et al. Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] F. Melchers,et al. A second gene, VpreB in the lambda 5 locus of the mouse, which appears to be selectively expressed in pre‐B lymphocytes. , 1987, The EMBO journal.
[26] T. Kmiecik,et al. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.
[27] S. Desiderio,et al. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. , 1990, Science.
[28] J. Parsons,et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] O. Witte,et al. Establishment of a reproducible culture technique for the selective growth of B-cell progenitors. , 1992, Current topics in microbiology and immunology.
[30] G. Daley,et al. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[31] K. Rajewsky,et al. A critical role of λ5 protein in B cell development , 1992, Cell.
[32] G. Martin,et al. Cellular localization of c-fps gene product NCP98 , 1984, Journal of virology.
[33] C. Denny,et al. Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Mohandas,et al. Assignment of human 3-hydroxy-3-methylglutaryl coenzyme A reductase gene to q13 → q23 region of chromosome 5 , 1986, Somatic cell and molecular genetics.
[35] S P Kwan,et al. Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus. , 1990, Genomics.
[36] T Pawson,et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.
[37] O. Witte,et al. Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Perlmutter,et al. Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin , 1987, Molecular and cellular biology.
[39] R. Davis,et al. Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity , 1984, Journal of virology.
[40] L. Shultz,et al. Genetically determined murine models of immunodeficiency. , 1987, Annual review of immunology.
[41] O. Witte,et al. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products , 1985, Molecular and cellular biology.
[42] S. Goff,et al. Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.
[43] D. Lipman,et al. Rapid and sensitive protein similarity searches. , 1985, Science.
[44] M. Conley,et al. Clonal diversity in the B cell repertoire of patients with X-linked agammaglobulinemia , 1989, The Journal of experimental medicine.
[45] F. Melchers,et al. λ5, a new light-chain-related locus selectively expressed in pre-B lymphocytes , 1986, Nature.
[46] J. Bolen,et al. src-related tyrosine protein kinases as signaling components in hematopoietic cells. , 1990, Cancer cells.
[47] M. Fellous,et al. A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.
[48] R. Perlmutter,et al. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.
[49] A. Wilks,et al. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase , 1991, Molecular and cellular biology.
[50] D. Smith,et al. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.
[51] D. Tuan,et al. The "beta-like-globin" gene domain in human erythroid cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[52] A. Rolink,et al. Molecular and cellular origins of B lymphocyte diversity , 1991, Cell.
[53] R. Levinsky,et al. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors. , 1989, Clinical and experimental immunology.
[54] M. Conley,et al. Molecular approaches to analysis of X-linked immunodeficiencies. , 1992, Annual review of immunology.
[55] H. Mano,et al. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. , 1990, Oncogene.
[56] Jonathan A. Cooper,et al. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src , 1991, Nature.
[57] H. Nakamura,et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. , 1991, The Journal of biological chemistry.
[58] S. Wadsworth,et al. Embryonic expression of a Drosophila src gene: alternate forms of the protein are expressed in segmental stripes and in the nervous system. , 1989, Genes & development.
[59] M. Cooper,et al. Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Cooper,et al. B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. , 1978, Journal of immunology.
[61] S. Latt,et al. Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism. , 1986, The Journal of clinical investigation.
[62] D. Campana,et al. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. , 1990, Journal of immunology.
[63] T. Pawson,et al. SH2 and SH3 domains: From structure to function , 1992, Cell.
[64] S. Antonarakis,et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[65] E. Krebs,et al. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA , 1985, Cell.
[66] A. Dunn,et al. Isolation and sequence of a cDNA corresponding to a src-related gene expressed in murine hemopoietic cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[67] Michael A. Bookman,et al. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.
[68] R. Klausner,et al. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[69] O. Witte,et al. Long-term culture of B lymphocytes and their precursors from murine bone marrow. , 1982, Proceedings of the National Academy of Sciences of the United States of America.